| Product NDC: | 0555-0098 | 
| Proprietary Name: | Clonazepam | 
| Non Proprietary Name: | Clonazepam | 
| Active Ingredient(s): | 2 mg/1 & nbsp; Clonazepam | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET, ORALLY DISINTEGRATING | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0555-0098 | 
| Labeler Name: | Barr Laboratories Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA077194 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20050811 | 
| Package NDC: | 0555-0098-96 | 
| Package Description: | 10 BLISTER PACK in 1 CARTON (0555-0098-96) > 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK | 
| NDC Code | 0555-0098-96 | 
| Proprietary Name | Clonazepam | 
| Package Description | 10 BLISTER PACK in 1 CARTON (0555-0098-96) > 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK | 
| Product NDC | 0555-0098 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Clonazepam | 
| Dosage Form Name | TABLET, ORALLY DISINTEGRATING | 
| Route Name | ORAL | 
| Start Marketing Date | 20050811 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Barr Laboratories Inc. | 
| Substance Name | CLONAZEPAM | 
| Strength Number | 2 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |